Skip to main content

Table 1 Perioperative variables in the non-aPRP group and aPRP group

From: Impact of autologous platelet rich plasma use on postoperative acute kidney injury in type A acute aortic dissection repair: a retrospective cohort analysis

Clinical variables Non-aPRP Group(n = 388) aPRP Group(n = 272) P Value
 Age (year) 49.29 ± 10.60 47.52 ± 9.77 0.030
 Males, n (%) 305 (78.4) 230 (84.6) 0.067
 Height (cm) 172.05 ± 7.51 171.49 ± 8.02 0.359
 Weight (kg) 77.02 ± 13.16 78.8 ± 13.20 0.073
 BMI (kg/M2) 25.97 ± 3.75 26.75 ± 3.70 0.009
 History of smoking, n (%) 137 (35.2) 120 (44.1) 0.023
 History of hypertension, n (%) 294 (75.8) 199 (73.2) 0.448
 History of DM, n (%) 18 (4.6) 13 (4.8) 0.933
 Time from onset of symptoms to surgery (d) 2 (1,4) 2 (1, 4) 0.768
preoperative
 LVEF (%) 60.22 ± 6.52 60.58 ± 6.302 0.490
 LVEDd (mm) 50.76 ± 8.71 49.888 ± 7.8517 0.195
EuroSCORE 5 (4.5,5) 5 (5,5) 0.408
 HR (beats/min) 80 ± 15 80 ± 15 0.334
 MBP (mm Hg) 89 ± 18 85 ± 22 0.014
 Hb(g/L) 12.68 ± 2.63 13.91 ± 4.14 0.001
 WBC (109/L) 10.91 ± 4.11 11.38 ± 3.72 0.135
 PLC(109 /L) 151 ± 76 171 ± 64 0.001
 LAC (mmol/L) 1.52 ± 0.95 1.56 ± 0.87 0.549
 SCr (umol/L) 102.9 ± 53.1 82.6 ± 37.6 < 0.001
 PT (second) 12.74 ± 2.29 12.81 ± 2.06 0.727
 PTA(100%) 87.03 ± 14.44 84.67 ± 14.67 0.128
 APTT (second) 32.83 ± 11.51 31.70 ± 6.76 0.211
 FIB(g/L) 3.30 ± 1.49 3.21 ± 1.56 0.571
 FDP (mg/L) 18.65 (9.01,31.45) 19.2 (10.2,35.65) 0.329
 D-D (ug/L) 1581 (850, 2976) 1836 (808, 2719) 0.660
 INR 1.09 (1.03,1.18) 1.11 (1.04,1.19) 0.192
Intraoperative
 With CABG 13 (5.2) 16 (6.5) 0.537
 Duration of surgery (min) 465 ± 99 492 ± 105 0.001
 Duration of CPB (min) 271.49 ± 172.64 281.27 ± 152.09 0.453
 Duration of Aortic cross-clamping (min) 92.97 ± 56.01 86.95 ± 54.77 0.171
 Lowest rectal temperature (°C) 25.21 ± 2.13 25.21 ± 1.79 0.966
 Lowest nasopharyngeal temperature (°C) 22.46 ± 6.02 22.91 ± 6.60 0.363
 Intravenous crystalloid (mL) 2153 ± 887 2354 ± 1133 0.015
 Allogeneic Red blood cells (units) 0 (0, 4) 0 (0, 3) 0.012
 Allogeneic blood Plasma (mL) 200 (0, 600) 0 (0,400) 0.001
aBlood product transfused (ml) 520 (0,1040) 375 (0,975) 0.014
 Urine volume during surgery (mL) 1591 ± 1073 1643 ± 863 0.503
Postoperative
 LVEF (%) 59.68 ± 7.04 59.59 ± 6.57 0.870
 HR (beats/min) 93 ± 17 94 ± 16 0.384
 MBP (mmHg) 88 ± 19 86 ± 20 0.20
 Hb(g/L) 10.23 ± 1.86 10.42 ± 1.57 0.545
 WBC (109/L) 11.48 ± 4.86 12.15 ± 4.57 0.20
 PLC(109 /L) 106 ± 51 97 ± 62 0.14
 LAC (mmol/L) 2.79 ± 3.12 3.97 ± 3.93 <0.001
 PT (second) 13.77 ± 4.45 13.18 ± 2.39 0.080
 PTA(100%) 82.81 ± 15.72 81.56 ± 14.86 0.442
 APTT (second) 32.63 ± 7.13 33.10 ± 12.04 0.628
 FIB(g/L) 3.34 ± 1.43 3.39 ± 1.97 0.731
 FDP (mg/L) 19 (9.17,32.4) 17.56 (9.52,35.67) 0.929
 D-D (ug/L) 1963 (855,3046) 1619 (815,2841) 0.510
 INR 1.12 (1.04,1.24) 1.14 (1.06,1.24) 0.323
 SCr (umol/L) 118.58 ± 72.59 105.89 ± 51.50 0.011
Postoperative 24 h
 SCr (umol/L) 133.1 ± 91.8 115.2 ± 66.6 0.005
 Seroma volume of drainage (mL) 1472 ± 667 1539 ± 820 0.263
Postoperative 48 h
 SCr (umol/L) 136.1 ± 106.3 122.3 ± 98.2 0.102
Postoperative 72 h
 SCr (umol/L) 113.4 ± 93.7 110.1 ± 77.5 0.737
  1. Data are given as numbers, percentage, mean ± standard deviation or median (interquartile range, IQR). BMI Body mass index, DM Diabetes mellitus, LVEF Left ventricular ejection fraction, LVEDD Left ventricular end diastolic diameter, EuroSCORE European system for cardiac operative risk evaluation, MBP Mean blood pressure, PLC Platelet count, Hb Hemoglobin, WBC White blood cells, LAC Lactic acid, FIB Fibrinogen, FDP Fibrinogen degradation product, APTT Active part thrombin time, PT Prothrombin time, APTT Activated partial thromboplastin time, PTA Prothrombin activityprothrombin time activity, INR International normalized ratio, D-D D-Dimer, SCr Serum creatine, CABG Coronary artery bypass grafting, CPB Cardiopulmonary bypass. aNumber of blood products transfused perioperatively was defined as total units of red blood cells (1 unit = 160 ml), fresh-frozen plasma and apheresis platelet units (1 unit = 260 ml) administered